RTM Vital Signs
Fort Washington
About RTM Vital Signs
This innovative approach transcends the limitations of ad hoc vital sign readings and periodic data transmissions and will support the much needed transformation of healthcare from reactive and hospital-centered to preventive, proactive, evidence-based, person-centered, and focused on well-being rather than on disease. Their approach partners technology-based solutions with biobehavioral health research that will produce continual data patterns transmitted to a central monitoring station that can be accessed by smart phones and the like for immediate and accurate physician diagnostic and dosage intervention. The device will employ sensor technology and can be managed in a non-invasive way. The accurate real time vital sign readings produced (including blood pressure) eliminate the issue of patient non-compliance and enable immediate intervention to avoid the costs of a heart attack or an emergency room visit for a false heart attack. This breakthrough will deliver value by cost-effectively improving the quality of life of patients while also keeping hospital costs down by reducing false admittance.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $455.0K
- Funding stage: Seed
- Last round: Seed (Nov 2020)
- Website: rtmvitalsigns.com
- Phone: 215-643-1286
Industries & Categories
Biotechnology, Health Care, Information Technology, Life Science, Medical
Canonical: https://fsome.com/organization/rtm-vital-signs-72429 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.